Quick turnaround time and updates. Made great changes based on the feedback we provided.
- brian H7
- solafide PDI™
Great design for my new logo and easy to work with. Thank you.
The designer was very customer oriented and delivered everything on time. Thank you very much for the great co-operation!
Logo, letterhead, etc.
Prolific and creative. Great rendering capabilities and fast to work with.
Excellent to work with, zero issues did everything I asked and very prompt on making changes when needed. Very easy to work with overall and very happy experience , would use again no question.
How paul.leonard started their logo & business card journey
Who are you known as?
Tell us a bit about who you are and the people you reach
Innovamab (INNOVAtion in Monoclonal AntiBody discovery) is a new biotech company focusing on monoclonal antibody drug discovery using their proprietary DiCAST discovery platform.
Monoclonal antibodies (Y-shaped proteins from our immune system) are the fastest growing class of biological drugs. Innovamab is using a combination of 1) innovative biology, 2) computer science and 3) mechanical engineering to provide a dynamic single cell (cells that produce antibodies) analysis process that can isolate the individual cells producing the next blockbuster antibody drugs. It does this in densely packed nanolitre - volume bio-incubation chambers (millions) in a miniature array.
We are looking for a logo that shows the dynamic integrative nature of the process. Antibody molecules have 3 domains and our process is made up of 3 integrated solutions (biology, computer and engineering) so a logo to represent three components interacting in a dynamic way would be great but not vital. Example logos/websites are provided at the end of this section but totally new concepts welcome.
In summary, we are looking for a modern dynamic logo possibly showing 1) 3 inter-dependent components interacting in some way, or 2) Y shape of monoclonal antibodies or 3) single cell analysis or 4) combination of the above or 5) new concepts.